CAS: 628-44-4; 2-Methyloctan-2-Ol

该化合物是一种以分子结构为特征的分链酒精,包括附于八烷链第二个碳的氢氧(-OH)组,这种化合物在室温下是一种无色液体,具有一种独特的,有点甜的酒精味,在有机溶剂中溶解,但由于其氢离水碳氢化合物链,在水中溶解性有限;氢氧化合物组的存在,具有中度极性,影响其再活动及与其他物质的相互作用;2-甲基乙醇可参与各种化学反应,包括脱水和氧化,使其在有机合成中有用,并可作为其他化学品生产的中间体;此外,它可能具有低挥发性和中度沸点等特性,在较大的酒精中很常见;安全考虑包括在通风良好的地区处理,并使用适当的个人防护设备,如许多有机溶剂和酒精.

结构式图片

相似化合物

78-69-3 13254-34-7 625-23-0

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号676-58-4 甲基氯化镁 | CAS号111-13-7 2-辛酮 | CAS号74-88-4 碘甲烷 | CAS号111-14-8 庚酸 | CAS号917-54-4 甲基锂 | CAS号115-18-4 2-甲基-3-丁烯-2-醇 | CAS号4588-18-5 2-甲基-1-辛烯 | CAS号67-64-1 丙酮 | CAS号592-41-6 1-己烯 | CAS号67-63-0 异丙醇 | CAS号544-10-5 氯(代)正己烷 | CAS号16993-86-5 2-METHYL-2-°CTENE | CAS号4588-18-5 2-甲基-1-辛烯 | CAS号29662-90-6 2,2-Dimethyl°Ct... | CAS号112-40-3 正十二烷 | CAS号3221-61-2 2-甲基辛烷 | CAS号60526-81-0 1-(1,1-二甲基庚基)-3... | CAS号30784-30-6 4-(2-methyl°Cta... | CAS号17312-73-1 5,5-Dimethylundecane | CAS号928-60-9 2-氯-2-甲基辛烷

合成工艺路线路线简述

    📜2-甲基辛烷置于[ruiii(5,10,15,20-Tetrakis(2,6-Difluorophenyl)Porphyrinato)(Ph)(Oh2)],四丁基高碘酸铵体系中,用 二氯甲烷 作为反应溶剂,以75%的收率获得产物2-甲基-2-辛醇
    参考文献:芳基钌 (Iii) 卟啉在室温下催化的 C-H 氧化和环氧化以及 [ruv(Por)(O)(Ph)] 中间体的光谱分析和密度泛函理论计算
    标题:芳基钌 (Iii) 卟啉在室温下催化的 C-H 氧化和环氧化以及 [ruv(Por)(O)(Ph)] 中间体的光谱分析和密度泛函理论计算
    摘要:开发用于烃类有效氧化的高活性和选择性金属催化剂以及氧化催化中反应中间体的鉴定是长期存在的挑战.在钌 (Iv) 和-(Iii) 卟啉催化的快速烃氧化中,推定的 Ru(V)-氧代中间体仍然难以捉摸.在此我们报告芳基钌 (Iii) 卟啉是烃氧化的高活性催化剂.使用催化剂 [ruiii(Tdcpp)(Ph)(Oet2)] (H2Tdcpp = 5,10,15,20-四(2,6-二氯苯基)卟啉),在氧化剂 M-Cpba 下氧化各种碳氢化合物的 Ch 键室温下,醇/酮在 1 小时内的收率高达 99%;使用 [Nbu4N]Io4 作为温和的替代氧化剂避免了 Ch 氧化中环酮形成内酯,催化环氧化反应在 5 分钟内完成,收率高达 99%,选择性高(无醛类副产物).uv-Vis,电喷雾电离质谱,共振拉曼,电子顺磁共振,动力学测量和密度泛函理论计算为 Ru(V)-氧代中间体 [ruv(Tdcpp)(O)(Ph)]
    DOI:10.1021/jacs.8B04470

    海关参考信息

    专利信息


    专利号:US-5118853-A
    优先权日:1988-10-13
    标题:Processes for the synthesis of 3-disubstituted aminoacroleins
    发明人:LEE GEORGE T; REPIC OLJAN
    权利人:SANDOZ LTD
    摘要:Process for the synthesis of compounds of the formula ##STR1## comprising the steps of (i) reacting a compound of the formula ##STR2## with oxalyl chloride or oxalyl bromide to form the corresponding compound of the formula ##STR3## (ii) reacting said compound of the formula ##STR4## with a compound of the formula ##STR5## to form the corresponding compound of the formula ##STR6## (iii) hydrolyzing said compound of the formula ##STR7## to obtain the corresponding compound of the formula ##STR8## the use of the compounds of the formula ##STR9## for the synthesis of the compounds of the formula ##STR10## and the use of the intermediates of Formula VII for the direct synthesis of the compounds of Formula II, n wherein n R 1 is C 1-3 alkyl, phenyl or phenyl substituted by 1 to 3 substituents each of which is independently C 1-3 alkyl, C 1-3 alkoxy, fluoro, chloro, bromo or nitro (maximum of two nitro groups), n R 1b is phenyl or phenyl substituted by 1 to 3 substituents each of which is independently C 1-3 alkyl, C 1-3 alkoxy, fluoro, chloro, bromo or nitro (maximum of two nitro groups), n R 2 is C 1-3 alkyl, n one of R 3 and R 4 is ##STR11## and the other is primary or secondary C 1-6 alkyl not containing an asymmetric carbon atom, C 3-6 cycloalkyl or phenyl-(CH 2 ) m -, n wherein n R 7 is hydrogen, C 1-3 alkyl, n-butyl, i-butyl, t-butyl, C 1-3 alkoxy, n-butoxy, i-butoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy, n R 8 is hydrogen, C 1-3 alkyl, C 1-3 alkoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy, n R 9 is hydrogen, C 1-2 alkyl, C 1-2 alkoxy, fluoro or chloro, and n m is 1, 2 or 3, with the provisos that not more than one of R 7 and R 8 is trifluoromethyl, not more than one of R 7 and R 8 is phenoxy, and not more than one of R 7 and R 8 is benzyloxy, n R 5 is hydrogen, C 1-3 alkyl, n-butyl, i-butyl, t-butyl, C 3-6 cycloalkyl, C 1-3 alkoxy, n-butoxy, i-butoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy, and n R 6 is hydrogen, C 1-3 alkyl, C 1-3 alkoxy, trifluoromethyl, fluoro, chloro, phenoxy, or benzyloxy, with the provisos that not more than one of R 5 and R 6 is trifluoromethyl, not more than one of R 5 and R 6 is phenoxy, and not more than one of R 5 and R 6 is benzyloxy, n R 10 is C 1-6 alkyl, each X is chloro or bromo, and each X.sup.⊖ is chloride or bromide.

    专利号:US-5840915-A
    优先权日:1990-01-22
    标题:Process for the enatioselective synthesis of intermediates used
    发明人:LEE THOMAS BING KIN; WONG GEORGE SEUNG-KIT
    权利人:HOECHST MARION ROUSSEL INC
    摘要:A process for the stereoselective synthesis of [R]- and [S]-2,3-dihydro-1,3-dimethyl-2-oxo-1H-indole-3-acetonitriles comprises reacting racemic and 5-alkoxy-substituted (+/-)-1,3-dimethyloxindoles with a halogenated acetonitrile in the presence of a substituted N-benzyl cinchoninium, quinidinium, cinchonidinium, or quininium catalyst. The resulting alkylated oxindoles can be converted to primary amines by catalytic reduction in the presence of hydrogen gas. One of the primary amines, such as enantiomers of 3-(2-aminoethyl)-1,3-dihydro-1,3-dimethyl-5-methoxy-2H-indol-2-one, can be enriched by contact with a chiral tartaric acid in an amount sufficient to preferentially precipitate a salt of the chiral acid and one of the enantiomers. The product can be used in the synthesis of stereospecific forms of physostigmine and related compounds having pharmaceutical activity.

    专利号:US-5274117-A
    优先权日:1990-01-22
    标 题:Process for the enantioselective synthesis of intermediates used in the preparation of physostigmine
    发明人:LEE THOMAS BING KIN DR; WONG GEORGE S K
    权利人:HOECHST ROUSSEL PHARMA
    摘要:A process for the stereoselective synthesis of [R]- and [S]-2,3-dihydro-1,3-dimethyl-2-oxo-1H-indole-3-acetonitriles comprises reacting racemic and 5-alkoxy-substituted (+/-)-1,3-dimethyloxindoles with a halogenated acetonitrile in the presence of a substituted N-benzyl cinchoninium, quinidinium, cinchonidinium, or quininium catalyst. The resulting alkylated oxindoles can be converted to primary amines by catalytic reduction in the presence of hydrogen gas. One of the primary amines, such as enantiomers of 3-(2-aminoethyl)-1,3-dihydro-1,3-dimethyl-5-methoxy-2H-indol-2-one, can be enriched by contact with a chiral tartaric acid in an amount sufficient to preferentially precipitate a salt of the chiral acid and one of the enantiomers. The product can be used in the synthesis of stereospecific forms of physostigmine and related compounds having pharmaceutical activity.

    专利号:US-5290946-A
    优先权日:1988-10-13
    标 题 :Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes
    发明人:LEE GEORGE T; KAPA PRASAD K; REPIC OLJAN
    权利人:SANDOZ LTD
    摘要:A process for synthesizing compounds of the formula ##STR1## utilizing, as intermediates, oxalyl chloride or bromide and compounds of the formulae R 1 R 2 N--CHO and CH 2 â•?CH--O--R 10 are processes for synthesizing compounds of the formula ##STR2## utilizing, as intermediates, compounds of Formula I wherein R 1 is phenyl or substituted phenyl or intermediates in the synthesis of the compounds of formula I which intermediates have the formula ##STR3## wherein R 1 is C 1-3 alkyl, phenyl or phenyl substituted by 1 to 3 substituents each of which is independently C 1-3 alkyl, C 1-3 alkoxy, fluoro, chloro, bromo or nitro (maximum of two nitro groups), n R 2 is C 1-3 alkyl, n R 10 is C 1-6 alkyl, n X.sup.⊖ is chloride or bromide, and n R 3 -R 6 are as defined in the specification. n The compounds of Formula II are intermediates in the synthesis of known HMB-CoA reductase inhibitors which inhibit the biosynthesis of cholesterol and are useful as antihyperchloesterolemic gents.

    专利号:EP-0438796-B1
    优先权日:1990-01-22
    标题:Process for the enantioselection synthesis of alkylated oxindoles used as intermediates in the preparation of physostigmine
    发明人:LEE THOMAS BING KIN DR; WONG GEORGE S K
    权利人:HOECHST MARION ROUSSEL INC
    摘要:A process for the stereoselective synthesis of [R]- and [S]-2,3-dihydro-1,3-dimethyl-2-oxo-1H-indole-3-acetonitriles comprises reacting racemic and 5-alkoxy-substituted (+/-)-1,3-dimethyloxindoles with a halogenated acetonitrile in the presence of a substituted N-benzyl cinchoninium, quinidinium, cinchonidinium, or quininium catalyst. The resulting alkylated oxindoles can be converted to primary amines by catalytic reduction in the presence of hydrogen gas. One of the primary amines, such as enantiomers of 3-(2-aminoethyl)-1,3-dihydro-1,3-dimethyl-5-methoxy-2H-indol-2-one, can be enriched by contact with a chiral tartaric acid in an amount sufficient to preferentially precipitate a salt of the chiral acid and one of the enantiomers. The product can be used in the synthesis of stereospecific forms of physostigmine and related compounds having pharmaceutical activity.

    专利号:US-7368568-B2
    优先权日:2001-08-03
    标 题 :Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for production and the use
    发明人:WESTERMANN JURGEN; PLATZEK JOHANNES; PETROV ORLIN
    权利人:BAYER SCHERING PHARMA AG
    摘要:The invention relates to new protected 3,5-dihydroxy-2,2-dimethyl-valeroarnides for the synthesis of edothilones and derivatives and process for the production and the use of the new compounds for the production of epothilones or epothilone derivatives.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Ilyashenko, G.; Schütz, T.; Whiting, A., Science of Synthesis, (2008) 36, 245.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知